ISPYRRA 4mg chewable tablets medication leaflet

R03DC03 montelukast • Respiratory system | Other systemic drugs for obstructive airway diseases | Leukotriene receptor antagonists

Montelukast is a medication used for the prevention and treatment of asthma, as well as for relieving symptoms of seasonal or perennial allergic rhinitis. It works by blocking leukotriene receptors, which are chemicals involved in inflammation, thereby reducing airway inflammation and constriction.

It is effective in preventing asthma attacks, especially those triggered by exercise or allergens, but it is not suitable for treating acute asthma attacks. Additionally, it helps reduce symptoms such as sneezing, nasal congestion, and itching associated with allergies.

Montelukast is generally well-tolerated but may cause side effects such as headaches, abdominal pain, or, more rarely, mood changes like anxiety or insomnia. Patients should follow the prescribed treatment and avoid stopping the medication without consulting their doctor.

This medication is typically used as an adjunct therapy in combination with other treatments for asthma or allergies.

General data about ISPYRRA 4mg

Substance: montelukast

Date of last drug list: 01-01-2014

Commercial code: W60152002

Concentration: 4mg

Pharmaceutical form: chewable tablets

Quantity: 28

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Pharmaceutical forms available for montelukast

Concentrations available for montelukast

10mg, 4mg, 4mg/sachet, 5mg